Cancer Treatment Today

NCCN MS-11 is supportive of multi-gene testing, such as MyridsMy RIsk when integrated into the context of genetic counseling before and after and notes that the same  recommendation was also made by ASCO in 2015.

Kotsopoulos J. BRCA Mutations and Breast Cancer Prevention. Cancers (Basel). 2018;10(12):524. Published 2018 Dec 19. doi:10.3390/cancers10120524

NCCN Breast Cancer Risk Reduction MS-11